99 related articles for article (PubMed ID: 1351152)
1. Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies.
Neppert J; Kissel K
Lancet; 1992 Jun; 339(8807):1481. PubMed ID: 1351152
[No Abstract] [Full Text] [Related]
2. Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR).
Dooren MC; Kuijpers RW; Joekes EC; Huiskes E; Goldschmeding R; Overbeeke MA; von dem Borne AE; Engelfriet CP; Ouwehand WH
Lancet; 1992 May; 339(8801):1067-70. PubMed ID: 1349101
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newborn.
Dooren MC; van Kamp IL; Kanhai HH; Gravenhorst JB; von dem Borne AE; Engelfriet CP
Vox Sang; 1993; 65(1):55-8. PubMed ID: 8362515
[TBL] [Abstract][Full Text] [Related]
4. High incidence of maternal HLA A, B and C antibodies associated with a mild course of haemolytic disease of the newborn. Group for the Study of Protective Maternal HLA Antibodies in the Clinical Course of HDN.
Neppert J; v Witzleben-Schürholz E; Zupanska B; Bartz L; Greve O; Eichler H; Kerowgan M; Wichmann MG
Eur J Haematol; 1999 Aug; 63(2):120-5. PubMed ID: 10480291
[TBL] [Abstract][Full Text] [Related]
5. Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn.
Hadley AG; Kumpel BM; Leader KA; Poole GD; Fraser ID
Br J Haematol; 1991 Feb; 77(2):221-8. PubMed ID: 2004024
[TBL] [Abstract][Full Text] [Related]
6. Correlation of monocyte-monolayer assay results, number of erythrocyte-bound IgG molecules, and IgG subclass composition in the study of red cell alloantibodies other than D.
Zupańska B; Brojer E; McIntosh J; Seyfried H; Howell P
Vox Sang; 1990; 58(4):276-80. PubMed ID: 2399692
[TBL] [Abstract][Full Text] [Related]
7. Haemolytic disease of the newborn due to anti-Mt a .
Field TE; Wilson TE; Dawes BJ; Giles CM
Vox Sang; 1972; 22(5):432-7. PubMed ID: 5032416
[No Abstract] [Full Text] [Related]
8. Haemolytic disease of the newborn because of rare anti-Vel.
van Gammeren AJ; Overbeeke MA; Idema RN; van Beek RH; Ten Kate-Booij MJ; Ermens AA
Transfus Med; 2008 Jun; 18(3):197-8. PubMed ID: 18598283
[TBL] [Abstract][Full Text] [Related]
9. [Functional evaluation of erythrocytic antibodies by photometric detection of erythrophagocytosis in the monocyte monolayer assay].
Cassens U; Garritsen HS; Sibrowski W; Holzgreve W
Geburtshilfe Frauenheilkd; 1996 Jun; 56(6):297-300. PubMed ID: 8766487
[TBL] [Abstract][Full Text] [Related]
10. The role of RH antibodies in causing haemolytic disease of the newborn and in preventing it.
Mollison PL
J Clin Pathol; 1971 Jul; 24(5):479-80. PubMed ID: 4999068
[No Abstract] [Full Text] [Related]
11. Mild course of fetal RhD haemolytic disease due to maternal alloimmunisation to paternal HLA class I and II antigens.
Eichler H; Zieger W; Neppert J; Kerowgan M; Melchert F; Goldmann SF
Vox Sang; 1995; 68(4):243-7. PubMed ID: 7660645
[TBL] [Abstract][Full Text] [Related]
12. [A new report of haemolytic disease of the newborn due to IgG anti-M (author's transl)].
Martin Vega C; Ribera A; Gallart MT; Triginer J
Sangre (Barc); 1980; 25(3):392-6. PubMed ID: 6968096
[No Abstract] [Full Text] [Related]
13. Anti-U and haemolytic disease of the fetus and newborn.
Smith G; Knott P; Rissik J; de la Fuente J; Win N
Br J Obstet Gynaecol; 1998 Dec; 105(12):1318-21. PubMed ID: 9883926
[TBL] [Abstract][Full Text] [Related]
14. Isoimmunization in pregnancy to Gerbich antigen.
Sacks DA; Johnson CS; Platt LD
Am J Perinatol; 1985 Jul; 2(3):208-10. PubMed ID: 4015769
[TBL] [Abstract][Full Text] [Related]
15. Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn.
Sonneveld ME; Koelewijn J; de Haas M; Admiraal J; Plomp R; Koeleman CA; Hipgrave Ederveen AL; Ligthart P; Wuhrer M; van der Schoot CE; Vidarsson G
Br J Haematol; 2017 Feb; 176(4):651-660. PubMed ID: 27891581
[TBL] [Abstract][Full Text] [Related]
16. [An at-risk pregnancy caused by an irregular complement-activating nonspecific alloantibody in maternal serum].
Ratei R
Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):731-2. PubMed ID: 3234706
[TBL] [Abstract][Full Text] [Related]
17. The prevention of rhesus-isoimmunization.
Davey M
Clin Obstet Gynaecol; 1979 Dec; 6(3):509-30. PubMed ID: 92385
[No Abstract] [Full Text] [Related]
18. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn.
Brinc D; Lazarus AH
Hematology Am Soc Hematol Educ Program; 2009; ():185-91. PubMed ID: 20008198
[TBL] [Abstract][Full Text] [Related]
19. Variable inhibition of placental IgG transfer in vitro with commercial IVgG preparations.
Urbaniak SJ; Duncan JI; Armstrong-Fisher SS; Abramovich DR; Page KR
Br J Haematol; 1999 Dec; 107(4):815-7. PubMed ID: 10606889
[TBL] [Abstract][Full Text] [Related]
20. IgG-mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the newborn?
Brinc D; Le-Tien H; Crow AR; Freedman J; Lazarus AH
Br J Haematol; 2007 Oct; 139(2):275-9. PubMed ID: 17897303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
